All News | Pharmya

2023 April Apr 11

How to limit the occurrence of adverse effects of mydriatic eye drops in children?

https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants?fbclid=IwAR0-r9IYprxvpZnb_cCXk249sawSqKCIWoxEv00kpqRWuMrMcqro7VGhg-s

2023 April Apr 07

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

2023 April Apr 03

About us – EMA

2023 March Mar 30

Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM

2023 March Mar 27

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

2023 March Mar 23

WHO Pharmaceuticals Newsletter

2023 March Mar 20

Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes

2023 March Mar 17

Guideline on computerised systems and electronic data in clinical trials

2023 March Mar 13

EU-PRAC recommendations on signals adopted at the 6-9 February 2023 meeting

2023 March Mar 09

Welcome to the team!

The Pharmya team is growing! A big welcome to Angélique, our new team assistant!